Boston Scientific Corp.

NYSE:BSX   3:59:59 PM EDT
38.16
-0.20 (-0.52%)
Products

Boston Scientific Receives FDA Approval For Expanded Labeling Of Watchman Flx™ Laac Device For Dual Anti-Platelet Therapy As Post-Procedural Medication Option

Published: 09/06/2022 11:41 GMT
Boston Scientific Corp. (BSX) - Boston Scientific Receives FDA Approval for Expanded Labeling of Watchman Flx™ Laac Device for Dual Anti-platelet Therapy As Post-procedural Medication Option.